Skip to main content
. Author manuscript; available in PMC: 2019 Dec 26.
Published in final edited form as: Diabetes Educ. 2019 Sep 3;45(5):529–543. doi: 10.1177/0145721719872553

Table 3.

Unadjusted Weight Outcomes From Baseline Overall and by Cardiometabolic Risk Groups

All Participants Baseline 3 Months 6 Months 12 Months 18 Months 24 Months
All participants, No. 3156 2851 2129 2334 2013 1736
 Weight, mean ± SD, kg 101.33 ± 23.84 98.10 ± 23.10 97.47 ± 23.47 97.79 ± 23.46 97.87 ± 23.31 98.38 ± 23.32
 Time to follow-up, mean ± SD, mo 2.60 ± 0.46 5.57 ± 0.69 11.76 ± 1.17 17.92 ± 1.27 24.02 ± 1.29
 Absolute weight change from baseline, mean (95% CI), kg −3.45 (−3.60 to −3.30) −4.05 (−4.33 to −3.78) −3.31 (−3.61 to −3.00) −2.66 (−2.97 to −2.34) −2.41 (−2.80 to −2.02)
 Percent weight change from baseline, mean (95% CI) −3.39 (−3.52 to −3.25) −3.92 (−4.17 to −3.67) −3.20 (−3.48 to −2.92) −2.57 (−2.87 −2.27) −2.27 (−2.61 to −1.92)
 ≥5% weight loss, No. (%) 833 (29.22) 769 (36.12) 712 (30.51) 574 (28.51) 505 (29.09)
 ≥7% weight loss, No. (%) 453 (15.89) 516 (24.24) 516 (22.11) 401 (19.92) 365 (21.03)
High risk for T2D, No. 1493 1381 1038 1106 940 824
 Weight, mean ± SD, kg 103.22 ± 24.33 99.22 ± 23.40 97.73 ± 23.71 98.26 ± 23.81 98.24 ± 23.53 99.49 ± 23.86
 Time to follow-up, mean ± SD, mo 2.61 ±7.52 5.58 ± 0.68 11.76 ± 1.17 17.93 ± 1.29 24.00 ± 1.33
 Absolute weight change from baseline, mean (95% CI), kg −3.81 (−4.04 to −3.60) −4.65 (−5.08 to −4.23) −3.79 (−4.24 to −3.34) −2.89 (−3.34 to −2.45) −2.85 (−3.46 to −2.25)
 Percent weight change from baseline, mean (95% CI) −3.69 (−3.89 to −3.50) −4.50 (−4.86 to −4.13) −3.69 (−4.10 to −3.28) −2.86 (−3.27 to −2.44) −2.68 (−3.20 to −2.17)
 ≥5% weight loss, No. (%) 445 (32.22) 421 (40.56) 375 (33.91) 280 (29.79) 260 (31.55)
 ≥7% weight loss, No. (%) 252 (18.25) 293 (28.23) 278 (25.14) 196 (20.85) 187 (22.69)
Overweight/obese, No. 858 748 511 575 490 410
 Weight, mean ± SD, kg 94.40 ± 20.55 91.50 ± 19.91 91.14 ± 20.77 91.20 ± 21.01 91.47 ± 20.67 90.60 ± 19.44
 Time to follow-up, mean ± SD, mo 2.58 ± 0.47 5.55 ± 0.68 11.76 ± 1.24 18.01 ±1.40 24.06 ± 1.34
 Absolute weight change from baseline, mean (95% CI), kg −3.23 (−3.53 to −2.94) −3.68 (−4.24 to −3.12) −2.91 (−3.47 to −2.33) −2.26 (−2.88 to −1.64) −1.76 (−2.45 to −1.07)
 Percent weight change from baseline, mean (95% CI) −3.42 (−3.71 to −3.13) −3.88 (−4.41 to −3.35) −3.04 (−3.61 to −2.47) −2.42 (−3.05 to −1.78) −1.88 (−2.59 to −1.17)
 ≥5% weight loss, No. (%) 234 (31.28) 191 (37.38) 161 (28.00) 129 (26.33) 121 (29.51)
 ≥7% weight loss, No. (%) 126 (16.84) 128 (25.05) 123 (21.39) 104 (21.22) 82 (20.00)
Existing T2D, No. 755 678 543 614 545 468
 Weight, mean ± SD, kg 106.14 ± 24.23 103.66 ± 23.67 103.22 ± 23.69 103.57 ± 23.11 103.56 ± 23.86 103.68 ± 23.81
 Time to follow-up, mean ± SD, mo 2.62 ± 0.49 5.57 ± 0.70 11.77 ± 1.09 17.83 ± 1.11 24.01 ±1.16
 Absolute weight change from baseline, mean (95% CI), kg −3.01 (−3.29 to −2.73) −3.40 (−3.88 to −2.73) −3.00 (−3.57 to −2.43) −2.78 (−3.43 to −2.13) −2.45 (−3.12 to −1.77)
 Percent weight change from baseline, mean (95%CI) −2.78 (−3.03 to −2.53) −3.03 (−3.45 to −2.61) −2.68 (−3.17 to −2.19) −2.46 (−3.02 to −1.90) −2.23 (−2.81 to −1.64)
 ≥5% weight loss, No. (%) 144 (21.24) 147 (27.07) 166 (27.04) 154 (28.26) 118 (25.21)
 ≥7% weight loss, No. (%) 72 (10.62) 92 (16.94) 111 (18.08) 96 (17.61) 91 (19.44)

Abbreviations: CI, confidence interval; SD, standard deviation; T2D, type 2 diabetes.

HHS Vulnerability Disclosure